{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,16]],"date-time":"2026-03-16T15:53:14Z","timestamp":1773676394749,"version":"3.50.1"},"reference-count":30,"publisher":"Elsevier BV","issue":"4","license":[{"start":{"date-parts":[[2025,11,1]],"date-time":"2025-11-01T00:00:00Z","timestamp":1761955200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,11,1]],"date-time":"2025-11-01T00:00:00Z","timestamp":1761955200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/501100002386","name":"Cairo University","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100002386","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100003009","name":"Science and Technology Development Fund","doi-asserted-by":"publisher","award":["5274"],"award-info":[{"award-number":["5274"]}],"id":[{"id":"10.13039\/501100003009","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Arab Journal of Gastroenterology"],"published-print":{"date-parts":[[2025,11]]},"DOI":"10.1016\/j.ajg.2025.09.005","type":"journal-article","created":{"date-parts":[[2025,11,6]],"date-time":"2025-11-06T05:02:48Z","timestamp":1762405368000},"page":"403-409","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":1,"title":["The utility of miRNA 221 & miRNA 199-a in the diagnosis of pancreatic adenocarcinoma"],"prefix":"10.1016","volume":"26","author":[{"ORCID":"https:\/\/orcid.org\/0009-0007-1661-8859","authenticated-orcid":false,"given":"Yosra Ayman","family":"Yosry","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Aisha","family":"Elsharkawy","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hussein Hassan","family":"Okasha","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Rabab","family":"Fouad","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ahmed","family":"Khairy","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Olfat","family":"Shaker","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hany","family":"khattab","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ayman","family":"Yosry","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7314-9242","authenticated-orcid":false,"given":"Younan Kabara","family":"Ayoub","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"issue":"1","key":"10.1016\/j.ajg.2025.09.005_b0005","first-page":"7","article-title":"Cancer statistics, 2018","volume":"68","author":"Siegel","year":"2018","journal-title":"CA Cancer J Clin"},{"key":"10.1016\/j.ajg.2025.09.005_b0010","doi-asserted-by":"crossref","first-page":"6015","DOI":"10.1158\/0008-5472.CAN-09-4531","article-title":"miRNA-96 suppresses KRAS and functions as a tumor suppressor gene in pancreatic cancer","volume":"70","author":"Yu","year":"2010","journal-title":"Cancer Res"},{"issue":"11","key":"10.1016\/j.ajg.2025.09.005_b0015","doi-asserted-by":"crossref","first-page":"2913","DOI":"10.1158\/0008-5472.CAN-14-0155","article-title":"Projecting cancer incidence and deaths to 2030: the unexpected burden of thyroid, liver, and pancreas cancers in the United States","volume":"74","author":"Rahib","year":"2014","journal-title":"Cancer Res"},{"key":"10.1016\/j.ajg.2025.09.005_b0020","doi-asserted-by":"crossref","first-page":"270","DOI":"10.7150\/ijbs.14950","article-title":"Pancreatic cancer: current progress and future challenges","volume":"12","author":"Hussain","year":"2016","journal-title":"Int J Biol Sci"},{"key":"10.1016\/j.ajg.2025.09.005_b0025","doi-asserted-by":"crossref","first-page":"10752","DOI":"10.3748\/wjg.v20.i31.10752","article-title":"Emerging role of the KRAS-PDK1 axis in pancreatic cancer","volume":"20","author":"Ferro","year":"2014","journal-title":"World J Gastroenterol"},{"key":"10.1016\/j.ajg.2025.09.005_b0030","doi-asserted-by":"crossref","first-page":"156","DOI":"10.1097\/01.mpa.0000168222.05591.a0","article-title":"Differential and synergistic effects of platelet-derived growth factor-BB and transforming growth factor-beta1 on activated pancreatic stellate cells","volume":"31","author":"Kordes","year":"2005","journal-title":"Pancreas"},{"key":"10.1016\/j.ajg.2025.09.005_b0035","doi-asserted-by":"crossref","first-page":"883","DOI":"10.1016\/j.cell.2010.01.025","article-title":"Immunity, inflammation, and cancer","volume":"140","author":"Grivennikov","year":"2010","journal-title":"Cell"},{"key":"10.1016\/j.ajg.2025.09.005_b0040","doi-asserted-by":"crossref","first-page":"395","DOI":"10.1038\/bjc.2013.346","article-title":"A derived neutrophil to lymphocyte ratio predicts clinical outcome in stage II and III colon cancer patients","volume":"109","author":"Absenger","year":"2013","journal-title":"Br J Cancer"},{"key":"10.1016\/j.ajg.2025.09.005_b0045","doi-asserted-by":"crossref","first-page":"350","DOI":"10.1186\/1471-2407-13-350","article-title":"Prognostic significance of neutrophil lymphocyte ratio and platelet lymphocyte ratio in advanced gastric cancer patients treated with FOLFOX chemotherapy","volume":"13","author":"Lee","year":"2013","journal-title":"BMC Cancer"},{"key":"10.1016\/j.ajg.2025.09.005_b0050","doi-asserted-by":"crossref","first-page":"58","DOI":"10.1186\/1477-7819-12-58","article-title":"Preoperative platelet lymphocyte ratio (PLR) is superior to neutrophil lymphocyte ratio (NLR) as a predictive factor in patients with esophageal squamous cell carcinoma","volume":"12","author":"Feng","year":"2014","journal-title":"World J Surg Oncol"},{"key":"10.1016\/j.ajg.2025.09.005_b0055","doi-asserted-by":"crossref","first-page":"3362","DOI":"10.1245\/s10434-011-1754-8","article-title":"Elevated preoperative neutrophil: lymphocyte ratio as a predictor of postoperative disease recurrence in esophageal cancer","volume":"18","author":"Sharaiha","year":"2011","journal-title":"Ann Surg Oncol"},{"key":"10.1016\/j.ajg.2025.09.005_b0060","doi-asserted-by":"crossref","first-page":"772","DOI":"10.1007\/s12094-015-1289-8","article-title":"High pretreatment neutrophil-lymphocyte ratio predicts recurrence and poor prognosis for combined small cell lung cancer","volume":"17","author":"Shao","year":"2015","journal-title":"Clin Transl Oncol"},{"issue":"2","key":"10.1016\/j.ajg.2025.09.005_b0065","first-page":"105","article-title":"The clinical utility of serum CA 19-9 in the diagnosis, prognosis and management of pancreatic adenocarcinoma: an evidence-based appraisal","volume":"3","author":"Ballehaninna","year":"2012","journal-title":"J Gastrointest Oncol"},{"key":"10.1016\/j.ajg.2025.09.005_b0070","doi-asserted-by":"crossref","first-page":"29877","DOI":"10.18632\/oncotarget.4924","article-title":"Pancreatic cancer-derived exosomes transfer miRNAs to dendritic cells and inhibit RFXAP expression via miR-212-3p","volume":"6","author":"Ding","year":"2015","journal-title":"Oncotarget"},{"issue":"6","key":"10.1016\/j.ajg.2025.09.005_b0075","first-page":"394","article-title":"Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries","volume":"68","author":"Bray","year":"2018","journal-title":"CA Cancer J Clin"},{"issue":"9","key":"10.1016\/j.ajg.2025.09.005_b0080","doi-asserted-by":"crossref","first-page":"1993","DOI":"10.1002\/ijc.22535","article-title":"Body mass index and pancreatic cancer risk: a meta-analysis of prospective studies","volume":"120","author":"Larsson","year":"2007","journal-title":"Int J Cancer"},{"issue":"1","key":"10.1016\/j.ajg.2025.09.005_b0085","first-page":"13","article-title":"Diabetes and risk of pancreatic cancer: a pooled analysis from the pancreatic cancer cohort consortium","volume":"24","author":"Elena","year":"2013","journal-title":"Cancer Causes Control"},{"issue":"10","key":"10.1016\/j.ajg.2025.09.005_b0090","doi-asserted-by":"crossref","first-page":"2065","DOI":"10.1093\/annonc\/mdu276","article-title":"Diabetes, antidiabetic medications, and pancreatic cancer risk: an analysis from the International Pancreatic Cancer Case-Control Consortium","volume":"25","author":"Bosetti","year":"2014","journal-title":"Ann Oncol"},{"issue":"4","key":"10.1016\/j.ajg.2025.09.005_b0095","doi-asserted-by":"crossref","first-page":"176","DOI":"10.1067\/mcn.2002.129579","article-title":"Pancreatic cancer","volume":"26","author":"Yeo","year":"2002","journal-title":"Curr Probl Cancer"},{"issue":"9791","key":"10.1016\/j.ajg.2025.09.005_b0100","doi-asserted-by":"crossref","first-page":"607","DOI":"10.1016\/S0140-6736(10)62307-0","article-title":"Pancreatic cancer","volume":"378","author":"Vincent","year":"2011","journal-title":"Lancet"},{"issue":"1","key":"10.1016\/j.ajg.2025.09.005_b0105","doi-asserted-by":"crossref","first-page":"64","DOI":"10.1002\/mc.20771","article-title":"Diabetes and pancreatic cancer","volume":"51","author":"Li","year":"2012","journal-title":"Mol Carcinog"},{"issue":"19","key":"10.1016\/j.ajg.2025.09.005_b0110","doi-asserted-by":"crossref","first-page":"2047","DOI":"10.3748\/wjg.v24.i19.2047","article-title":"Challenges in diagnosis of pancreatic cancer","volume":"24","author":"Zhang","year":"2018","journal-title":"World J Gastroenterol"},{"key":"10.1016\/j.ajg.2025.09.005_b0115","doi-asserted-by":"crossref","first-page":"333","DOI":"10.1016\/j.amjsurg.2008.12.031","article-title":"CA19-9 serum levels in obstructive jaundice: clinical value in benign and malignant conditions","volume":"198","author":"Marrelli","year":"2009","journal-title":"Am J Surg"},{"key":"10.1016\/j.ajg.2025.09.005_b0120","doi-asserted-by":"crossref","first-page":"7459","DOI":"10.1007\/s13277-014-1995-9","article-title":"Diagnostic value of serum carbohydrate antigen 19-9 in pancreatic cancer: a meta-analysis","volume":"35","author":"Huang","year":"2014","journal-title":"Tumour Biol"},{"key":"10.1016\/j.ajg.2025.09.005_b0125","doi-asserted-by":"crossref","first-page":"685","DOI":"10.1097\/MPA.0b013e318243a905","article-title":"MicroRNA expression aids the preoperative diagnosis of pancreatic ductal adenocarcinoma","volume":"41","author":"Panarelli","year":"2012","journal-title":"Pancreas"},{"issue":"5","key":"10.1016\/j.ajg.2025.09.005_b0130","first-page":"465","article-title":"Down-regulation of miR-221 inhibits proliferation of pancreatic cancer cells through up-regulation of PTEN, p27^kip1, p57^kip2, and PUMA","volume":"3","author":"Sarkar","year":"2013","journal-title":"Am J Cancer Res"},{"issue":"13","key":"10.1016\/j.ajg.2025.09.005_b0135","doi-asserted-by":"crossref","first-page":"16396","DOI":"10.18632\/oncotarget.7651","article-title":"MicroRNA-199a and -214 as potential therapeutic targets in pancreatic stellate cells in pancreatic tumor","volume":"7","author":"Kuninty","year":"2016","journal-title":"Oncotarget"},{"issue":"3","key":"10.1016\/j.ajg.2025.09.005_b0140","doi-asserted-by":"crossref","first-page":"1583","DOI":"10.1007\/s11033-020-05245-5","article-title":"CA19-9 capability as predictor of pancreatic cancer resectability in a Spanish cohort","volume":"47","author":"Herreros-Villanueva","year":"2020","journal-title":"Mol Biol Rep"},{"issue":"5","key":"10.1016\/j.ajg.2025.09.005_b0145","doi-asserted-by":"crossref","first-page":"1989","DOI":"10.3390\/jcm12051989","article-title":"The prognostic and predictive role of the neutrophil-to-lymphocyte ratio, platelet-to-lymphocyte ratio, and lymphocyte-to-monocyte ratio as biomarkers in resected pancreatic cancer","volume":"12","author":"Maloney","year":"2023","journal-title":"J Clin Med"},{"key":"10.1016\/j.ajg.2025.09.005_b0150","doi-asserted-by":"crossref","first-page":"341","DOI":"10.1186\/s12935-020-01529-9","article-title":"MicroRNA-221-3p is related to survival and promotes tumour progression in pancreatic cancer: a comprehensive study on functions and clinicopathological value","volume":"20","author":"Wu","year":"2020","journal-title":"Cancer Cell Int"}],"container-title":["Arab Journal of Gastroenterology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1687197925001212?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1687197925001212?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,2,19]],"date-time":"2026-02-19T15:01:05Z","timestamp":1771513265000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1687197925001212"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,11]]},"references-count":30,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2025,11]]}},"alternative-id":["S1687197925001212"],"URL":"https:\/\/doi.org\/10.1016\/j.ajg.2025.09.005","relation":{},"ISSN":["1687-1979"],"issn-type":[{"value":"1687-1979","type":"print"}],"subject":[],"published":{"date-parts":[[2025,11]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"The utility of miRNA 221 & miRNA 199-a in the diagnosis of pancreatic adenocarcinoma","name":"articletitle","label":"Article Title"},{"value":"Arab Journal of Gastroenterology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ajg.2025.09.005","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 Pan-Arab Association of Gastroenterology. Published by Elsevier B.V. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}]}}